The authors are members of the Australian Centre for Viral Hepatitis Inc.
Intrahepatic and peripheral blood virus-specific cytotoxic T lymphocyte activity is associated with a response to combination IFN-α and ribavirin treatment among patients with chronic hepatitis C virus infection*
Version of Record online: 20 JAN 2005
Journal of Viral Hepatitis
Volume 12, Issue 2, pages 125–129, March 2005
How to Cite
Freeman, A. J., Marinos, G., Ffrench, R. A. and Lloyd, A. R. (2005), Intrahepatic and peripheral blood virus-specific cytotoxic T lymphocyte activity is associated with a response to combination IFN-α and ribavirin treatment among patients with chronic hepatitis C virus infection. Journal of Viral Hepatitis, 12: 125–129. doi: 10.1111/j.1365-2893.2005.00565.x
- Issue online: 31 JAN 2005
- Version of Record online: 20 JAN 2005
- Received November 2003; accepted for publication February 2004
- cytotoxic T lymphocytes;
- viral load
Summary. This report describes an association between intrahepatic and peripheral blood cytotoxic T lymphocytes (CTL) activity present prior to receiving treatment, and a response to combination interferon-α (IFN-α) and ribavirin therapy for chronic hepatitis C virus (HCV) infection. Recombinant vaccinia virus constructs were used to expand and detect cytotoxic effectors against the entire genotype 1a HCV polyprotein. Six patients with a sustained response to therapy were significantly more likely to display intrahepatic and peripheral blood HCV-specific CTL activity than patients who relapsed or had no treatment response. Limited longitudinal data suggested that rather than combination therapy acting to enhance the CTL response to achieve viral clearance, detectable CTL prior to treatment increases the likehood of the host responding to the direct antiviral activity of IFN-α and ribavirin.